Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Nolan

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Cell|September 23, 1997
Harnessing viral devices as pharmaceuticals: fighting HIV-1's fire with fireG P Nolan
Nature Biotechnology|September 5, 2001
Genetic selection and the lure of SING P Nolan
Cell|June 17, 1994
NF-AT-AP-1 and Rel-bZIP: hybrid vigor and binding under the influenceG P Nolan
Nature|March 27, 1998
Cardiac development. Transcription and the broken heartG P Nolan
Current Directions in Autoimmunity|January 17, 2002
Retroviral and lentiviral gene therapy for autoimmune diseaseR Smith, G P Nolan
Current Opinion in Genetics & Development|April 1, 1992
The inhibitory ankyrin and activator Rel proteinsG P Nolan, D Baltimore
Gene Therapy|February 11, 2005
Gene therapy progress and prospects: novel gene therapy approaches for AIDSR Wolkowicz, G P Nolan
Human Gene Therapy|August 1, 1996
Episomal vectors rapidly and stably produce high-titer recombinant retrovirusT M Kinsella, G P Nolan
Immunity|December 1, 2001
Resistance is futile: assimilation of cellular machinery by HIV-1O D Perez, G P Nolan
Current Topics in Microbiology and Immunology|March 15, 2002
Nonprimate lentiviral vectorsM A Curran, G P Nolan
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Cell|September 23, 1997
Harnessing viral devices as pharmaceuticals: fighting HIV-1's fire with fireG P Nolan
Nature Biotechnology|September 5, 2001
Genetic selection and the lure of SING P Nolan
Cell|June 17, 1994
NF-AT-AP-1 and Rel-bZIP: hybrid vigor and binding under the influenceG P Nolan
Nature|March 27, 1998
Cardiac development. Transcription and the broken heartG P Nolan
Current Directions in Autoimmunity|January 17, 2002
Retroviral and lentiviral gene therapy for autoimmune diseaseR Smith, G P Nolan
Current Opinion in Genetics & Development|April 1, 1992
The inhibitory ankyrin and activator Rel proteinsG P Nolan, D Baltimore
Gene Therapy|February 11, 2005
Gene therapy progress and prospects: novel gene therapy approaches for AIDSR Wolkowicz, G P Nolan
Human Gene Therapy|August 1, 1996
Episomal vectors rapidly and stably produce high-titer recombinant retrovirusT M Kinsella, G P Nolan
Immunity|December 1, 2001
Resistance is futile: assimilation of cellular machinery by HIV-1O D Perez, G P Nolan
Current Topics in Microbiology and Immunology|March 15, 2002
Nonprimate lentiviral vectorsM A Curran, G P Nolan
Pageof 9